MacroGenics
MGNX
#8653
Rank
C$0.33 B
Marketcap
C$5.21
Share price
-7.73%
Change (1 day)
127.77%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of March 2026 : C$29.85 Million

According to MacroGenics's latest financial reports the company has C$29.85 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$C$76.13 M-54.29%
2024-12-31$C$0.16 B-17.73%
2023-12-31$C$0.20 B5.04%
2022-12-31$C$0.19 B-36.9%
2021-12-31$C$0.30 B-19.06%
2020-12-31$C$0.37 B25.25%
2019-12-31$C$0.30 B-8.96%
2018-12-31$C$0.33 B-12.06%
2017-12-31$C$0.37 B4.17%
2016-12-31$C$0.36 B-16.91%
2015-12-31$C$0.43 B208.82%
2014-12-31$C$0.14 B67.55%
2013-12-31$C$84 M-1125.54%
2012-12-31$-C$8.2 Million-53.94%
2011-12-31$-C$17.79 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
C$127.34 B 426,374.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.94 B 147,074.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.94 B 43,253.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$33.00 B 110,434.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$64.69 B 216,576.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$28.31 B 94,729.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.72 B 2,332.46%๐Ÿ‡บ๐Ÿ‡ธ USA